Nkarta (NKTX, $6.65) was a top loser yesterday, declining -1 to $6.65 per share. Of the 879 stocks analyzed in the Biotechnology Industry, of them () exhibited an Uptrend while of them () were in a Downtrend. 258 similar cases when NKTX's price dropped within one day were found. In out of those 258 cases, NKTX's price went down during the subsequent month. Based on these historical data, the odds of a Downtrend continuation for NKTX are
a biopharmaceutical company, which engages in the discovery, development, and commercialization of natural killer cell therapies for the treatment of cancer